Since MLL rearrangement is associated with a dismal prognosis in acute leukemia, expression of CD93 in the LSC compartment of AML cases may be a useful surrogate marker to identify this AML subgroup25. This evidence concerns the gene KMT2A and acute myeloid leukemia.